Postmenopausal hormone therapy ‘ups breast cancer risk’
October 20th, 2010 - 2:45 pm ICT by ANIWashington, Oct 20 (ANI): Use of estrogen plus progestin among postmenopausal women is associated with an increased incidence of more advanced breast cancers and with a higher risk of deaths attributable to breast cancer, recent study reveals.
As part of the study, a total of 16,608 postmenopausal women ages 50 to 79 years with no prior hysterectomy from 40 U.S. clinical centers were randomly assigned to receive combined conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, or placebo pill.
After the original trial completion date re-consent was required for continued follow-up for breast cancer incidence and was obtained from 12,788 of the surviving participants.
The researchers found that in intention-to-treat analyses including all randomized participants and censoring those not consenting to additional follow-up, estrogen plus progestin compared with placebo increased the incidence of invasive breast cancer.
A significantly larger fraction of women in the combined hormone therapy group had breast cancers with positive lymph nodes compared with women in the placebo group.
“More women died of breast cancer in the combined hormone therapy group compared with the placebo group (25 deaths [0.03 percent per year] vs. 12 deaths [0.01 percent per year]), representing 2.6 vs. 1.3 deaths per 10,000 women per year, respectively,” the authors write.
The study was published in the October 20 issue of JAMA. (ANI)
- Estrogen not linked to lung cancer mortality in postmenopausal women - Aug 14, 2010
- Estrogen therapy 'ups kidney stones risk' in postmenopausal women - Oct 12, 2010
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Breast tenderness during hormone replacement therapy may indicate cancer risk - Oct 13, 2009
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Estrogen alone can cut risk of breast cancer - Dec 10, 2010
- Soy food safe for breast cancer survivors - Apr 06, 2011
- Menopausal hormone therapy 'ups ovarian cancer risk' - Nov 10, 2010
- HRT raises risk of kidney stones - Oct 13, 2010
- Drop in breast cancer rates linked to reduced hormone therapy - Dec 01, 2010
- Hormone replacement therapy cuts colorectal cancer risk in women - Jan 08, 2009
- Combination menopausal hormone therapy ups heart disease risk - Feb 17, 2010
- Soy intake lowers breast cancer recurrence in hormone-sensitive cancers - Oct 19, 2010
Tags: breast cancer, breast cancer incidence, breast cancer risk, breast cancers, completion date, deaths, equine, estrogen plus progestin, hormone therapy, hysterectomy, invasive breast cancer, lymph nodes, medroxyprogesterone, medroxyprogesterone acetate, placebo group, placebo pill, postmenopausal women, therapy group, ups, women ages